ArticleScientific reports2025
Ecytonucleospora hepatopenaei causes lipid droplet depletion and imbalanced lipid metabolism in Penaeus vannamei.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Ecytonucleospora hepatopenaei (EHP) infection in Penaeus vannamei causes significant economic losses in shrimp aquaculture due to growth retardation. Unable to generate ATP, EHP obligately relies on host energy production to survive. We hypothesize that EHP may potentially disrupt its host's lipid metabolism as lipid is the most energy-dense resource. To this end, the effects of EHP infection on lipid metabolism were investigated by evaluating activities and expressions of digestive enzymes, accumulation of lipid droplets, and expression of genes involved in lipid breakdown and synthesis. Results revealed that EHP infection progressively diminished digestive enzyme activities, leading to reduced nutrient availability. A persistent reduction of lipid droplet accumulation was detected from the onset of EHP infection. The marked decrease in the early stages was attributable to increased lipid droplet breakdown outpacing lipid synthesis. In the later stage, a partial recovery of lipid synthesis gene expression was observed; however, this was insufficient to counteract increased lipid breakdown, as genes in this pathway were upregulated. Ultimately, this imbalance resulted in a marked depletion of lipid droplets. These findings highlight how EHP infection chronically impairs digestion, drains lipid reservoir of its host and, eventually, retards growth. In terms of a potential practical solution, this study implies that dietary lipid supplementation might alleviate the metabolic disruption of EHP and, thereby, lessen the extent of growth retardation in infected population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.